Compare IMMX & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMMX | PAYS |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 784.8M | 780.3M |
| IPO Year | 2021 | 2020 |
| Metric | IMMX | PAYS |
|---|---|---|
| Price | $7.92 | $9.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $24.05 | $14.81 |
| AVG Volume (30 Days) | ★ 1.2M | 1.2M |
| Earning Date | 11-12-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 85.71 |
| EPS | N/A | ★ 0.30 |
| Revenue | N/A | ★ $24,120,434.00 |
| Revenue This Year | N/A | $40.90 |
| Revenue Next Year | N/A | $12.70 |
| P/E Ratio | ★ N/A | $31.48 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.78 | $3.08 |
| 52 Week High | $15.10 | $16.15 |
| Indicator | IMMX | PAYS |
|---|---|---|
| Relative Strength Index (RSI) | 42.67 | 26.49 |
| Support Level | $7.82 | $8.26 |
| Resistance Level | $9.04 | $14.06 |
| Average True Range (ATR) | 0.62 | 1.17 |
| MACD | 0.16 | -0.68 |
| Stochastic Oscillator | 41.81 | 3.13 |
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The The company generates revenues from pharma card programs through card program management fees, transaction claim processing fees, interchange fees, customer service fees, other billable service fees and settlement income and other revenues are generated through cardholder fees, interchange fees, program management fees, load fees and breakage.